Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

U.S. - top OTC medication types based on sales 2013

Top 10 OTC medication types in the U.S. based on sales in 2013 (in million U.S. dollars)*

by Statista Research Department, last edited Aug 29, 2013
U.S. - top OTC medication types based on sales 2013 This statistic shows the top ten OTC (over-the-counter) medication types in the United States based on sales in 2013. Most popular were nutritional supplements with a sales volume of approximately 6.7 billion U.S. dollars.
Show more

Top 10 OTC medication types in the U.S. based on sales in 2013 (in million U.S. dollars)*

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Headache and migraine in the U.S."
  • Prevalence
  • Migraines
  • Migraine symptoms/comorbidities
  • Migraine impacts
  • Relief
  • Top analgesic tablet brands
  • Miscellaneous
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.